Literature DB >> 11869077

Comparison of collagenase-cleaved articular cartilage collagen in mice in the naturally occurring STR/ort model of osteoarthritis and in collagen-induced arthritis.

J S Price1, M G Chambers, A R Poole, A Fradin, R M Mason.   

Abstract

OBJECTIVE: The STR/ort mouse develops a naturally occurring osteoarthritis of the femorotibial joint that provides a model with which to establish the time course of biochemical changes taking place in articular cartilage in the disease. Our objective was to define the onset, location and progression of type II collagen cleavage by collagenase in the tibial cartilage of the STR/ort mouse. For comparison, cartilage collagen cleavage was also studied in collagen-induced arthritis in DBA mice.
DESIGN: STR and control CBA mice aged 6-45 weeks were examined. DBA/1 mice were studied 2 and 3 weeks after initiating collagen-induced arthritis. Collagen cleavage was detected by immunolocalization using the antibody COL2-3/4Cshort which recognizes a carboxy terminal neoepitope created by collagenase cleavage of type I and II collagens.
RESULTS: No COL 2-3/4Cshort immunostaining was observed in the intact cartilage of healthy young or old mice. The earliest detectable collagen degradation occurred at the cartilage surface coincident with the appearance of surface roughening. As fibrillations developed, further collagen degradation was evident around the edge of the lesion and in adjacent extracellular matrix. In contrast, staining was observed throughout the cartilage matrix in type II collagen-induced arthritis prior to the development of histopathological lesions.
CONCLUSION: No evidence was found for collagen cleavage in intact/pre-lesional cartilage from STR/ort mice. Local collagen cleavage was, however, clearly associated with very early histopathological lesions and immunostaining with COL 2-3/4Cshort increased with progression of the latter. In contrast, type II collagen cleavage occurs throughout the articular cartilage at an early stage in collagen-induced arthritis. Copyright 2002 OsteoArthritis Research Society International.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869077     DOI: 10.1053/joca.2001.0500

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  5 in total

1.  In vivo expression of inflammatory cytokine receptors in the joint compartments of patients with arthritis.

Authors:  Tania Silvestri; Lia Pulsatelli; Paolo Dolzani; Luigi Frizziero; Andrea Facchini; Riccardo Meliconi
Journal:  Rheumatol Int       Date:  2005-03-16       Impact factor: 2.631

2.  Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031.

Authors:  Takeshi Ishikawa; Fusako Nishigaki; Susumu Miyata; Yoshitaka Hirayama; Kyoko Minoura; Junko Imanishi; Masahiro Neya; Tsuyoshi Mizutani; Yoshimasa Imamura; Yoichi Naritomi; Hidetsugu Murai; Yoshitaka Ohkubo; Akira Kagayama; Seitaro Mutoh
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

3.  Anti-inflammatory effects of Vitis thunbergii var. taiwaniana on knee damage associated with arthritis.

Authors:  Ching-Fent Tsai; Kun-Teng Wang; Lih-Geeng Chen; Chia-Jung Lee; Sung-Hui Tseng; Ching-Chiung Wang
Journal:  J Med Food       Date:  2014-04       Impact factor: 2.786

4.  Association of metalloproteinases, tissue inhibitors of matrix metalloproteinases, and proteoglycans with development, aging, and osteoarthritis processes in mouse temporomandibular joint.

Authors:  Amira Gepstein; Gil Arbel; Israel Blumenfeld; Micha Peled; Erella Livne
Journal:  Histochem Cell Biol       Date:  2003-06-21       Impact factor: 4.304

Review 5.  The STR/ort mouse model of spontaneous osteoarthritis - an update.

Authors:  K A Staines; B Poulet; D N Wentworth; A A Pitsillides
Journal:  Osteoarthritis Cartilage       Date:  2016-12-11       Impact factor: 6.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.